MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
MannKind Corporation (Nasdaq: MNKD) announced that its CEO, Michael Castagna, PharmD, will present at the 2023 Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 11:15 AM PST in San Francisco, California. Interested parties can listen to the webcast on the company's website, which will also be archived for replay. MannKind focuses on developing innovative therapeutic products for endocrine and orphan lung diseases, emphasizing rapid medicine delivery through their signature inhalation devices.
- None.
- None.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on the development and commercialization of innovative therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the 2023 Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:15 AM PST at the Westin St. Francis Hotel in San Francisco, California.
Those interested in listening to the webcast may do so by visiting the Company's website at Investors/Events & Presentations or https://investors.mannkindcorp.com/events-and-presentations. The webcast will also be archived and available for replay.
About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.
We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation.
With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.
Please visit mannkindcorp.com to learn more, and follow us on LinkedIn, Facebook, Twitter or Instagram.
MannKind Contact:
Rose Alinaya, Investor Relations
(818) 661-5000
Email: ir@mannkindcorp.com
FAQ
What is MannKind Corporation's stock symbol?
When will MannKind's CEO present at the J.P. Morgan Healthcare Conference?
Where is the 2023 J.P. Morgan Healthcare Conference being held?
How can I listen to MannKind's presentation at the conference?
What are MannKind Corporation's main areas of focus?
